Global Contrast Agents Market Growth 2023-2029

Global Contrast Agents Market Growth 2023-2029

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

LPI (LP Information)' newest research report, the “Contrast Agents Industry Forecast” looks at past sales and reviews total world Contrast Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Contrast Agents sales for 2023 through 2029. With Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast Agents industry.

This Insight Report provides a comprehensive analysis of the global Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Contrast Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast Agents.

The global Contrast Agents market size is projected to grow from US$ 5269.8 million in 2022 to US$ 8377.7 million in 2029; it is expected to grow at a CAGR of 8377.7 from 2023 to 2029.

Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.

Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.

In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.

This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

X-ray and CT

MRI

Ultrasound

Segmentation by application

Hospitals

Clinics

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

GE Healthcare

Bayer

Bracco Imaging

Guerbet Group

Hengrui Medicine

Lantheus

YRPG

BeiLu Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Contrast Agents market?

What factors are driving Contrast Agents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Contrast Agents market opportunities vary by end market size?

How does Contrast Agents break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.